Mirada Medical Expands U.S. Operations - Relocates to Denver
(firmenpresse) - DENVER, CO and OXFORD, UNITED KINGDOM -- (Marketwire) -- 06/07/12 -- Mirada Medical announced today that it is opening its new U.S. headquarters in Denver, Colorado. The move is in response to the company's growing U.S. installed base, which has experienced a six fold expansion over the past three years. Plans for the new facility call for expanded service, sales, customer support and operations for continued North American growth.
stated Mary Beth Archibald, Executive VP of U.S. Operations.
Mirada Medical is a world leader in advanced imaging and analysis software. They are well known for their breakthrough deformable registration technology, which has set the highest validated standard for multi-modality image registration, or image fusion. Deformable registration is the unique basis for a family of Mirada software products that help customers get more information out of their imaging studies, more efficiently, with more productive physicians and, most importantly, better patient care and outcomes.
Is Mirada's flagship multi-modality image review and analysis software. It allows radiologists to precisely align images and utilize customized reading layouts and workflows to read any combination of PET, CT, MR and SPECT.
allows the radiologist to efficiently prepare and present multi-modality images and quantitative analysis during tumor board meetings where referrers, such as oncologists, surgeons, and radiation oncologists, will be in attendance.
further differentiates Mirada users' PET/CT service by providing referrers with patient images, data and comprehensive reports quickly and securely.
employs the precision of modality specific deformable registration to enhance radiotherapy planning and assessment.
Mirada Medical will be demonstrating the latest features of their XD3 advanced imaging and analysis software, plus Casemeeting for tumor board and their new Caseaccess secure referral portal, at the annual Society of Nuclear Medicine meeting, booth 619, in Miami, Florida June 9-12.
Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada's products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere.
The company specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Mirada's advanced software products are available throughout the world under its own brand, and on an OEM basis through a select number of the world's leading healthcare companies.
Mirada Medical was originally spun out of the University of Oxford. The company's technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada's world headquarters in Oxford, England.
Mirada Medical, XD3, Casemeeting, Caseaccess and RTx are all trademarks of Mirada Medical Ltd.
Mirada Medical Denver office release
You can find PDF here:
US/Worldwide:
Robert Ripley
tel: (440) 591-8638
Insource Communications
Mirada Medical USA, Inc.
999 18th Street
Suite 2025N
Denver, CO 89292
Tel: (303) 379-9228
Oxford Centre for Innovation
New Road, Oxford
OX1 1BY
United Kingdom
Tel: +44(0)1865 261410
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.06.2012 - 06:28 Uhr
Sprache: Deutsch
News-ID 154070
Anzahl Zeichen: 0
contact information:
Town:
DENVER, CO and OXFORD, UNITED KINGDOM
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mirada Medical Expands U.S. Operations - Relocates to Denver"
steht unter der journalistisch-redaktionellen Verantwortung von
Mirada Medical (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
